GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: SCE-2787
cefozopran is an approved drug (Japan)
Compound class:
Synthetic organic
Comment: Cefozopran is a fourth generation cephalosporin, belonging to the β-lactam class of antibacterial compounds. It has broad-spectrum activity and was developed by Takeda for parenteral treatment of infections caused by a range of Gram-positive and Gram-negative bacteria [1-2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. Japan PMDA (0) |
IUPAC Name ![]() |
| (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-f]pyridazin-4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6918 | cefozopran |
Synonyms ![]() |
| SCE-2787 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Cefozopran |
| Other databases | |
| CAS Registry No. | 113359-04-9 (source: Scifinder) |
| ChEBI | CHEBI:3502 |
| ChEMBL Ligand | CHEMBL1276663 |
| DrugBank Ligand | DB13667 |
| DrugCentral Ligand | 551 |
| GtoPdb PubChem SID | 472319176 |
| PubChem CID | 9571080 |
| Search Google for chemical match using the InChIKey | QDUIJCOKQCCXQY-WHJQOFBOSA-N |
| Search Google for chemicals with the same backbone | QDUIJCOKQCCXQY |
| Search PubMed clinical trials | cefozopran |
| Search PubMed titles | cefozopran |
| Search PubMed titles/abstracts | cefozopran |
| UniChem Compound Search for chemical match using the InChIKey | QDUIJCOKQCCXQY-WHJQOFBOSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | QDUIJCOKQCCXQY-WHJQOFBOSA-N |